Clinical Trials Logo

Clinical Trial Summary

This study aims to evaluate the safety and efficacy of upper aerodigestive tract cryotherapy treatment in patients with refractory neurogenic cough in a prospective pilot study with a validated patient reported outcome measure


Clinical Trial Description

This study aims to test a new type of treatment for patients suffering from chronic cough, also known as upper airway cough syndrome. The new treatment involves the use of laryngeal cryotherapy which is the therapeutic freezing of tissue in the throat to numb the overactive sensory nerves in the throat which is believed to reduce cough symptoms. Patients will first undergo a flexible scope of the throat (laryngoscopy) to test for hypersensitive areas in the throat, then undergo the cryotherapy procedure in the office. After that, patients will be followed up in the clinic with the usual standard of care visits and undergo validated cough surveys to track their cough symptoms after the procedure. Possible side effects to this procedure are listed in detail below, and include temporary throat pain and coughing. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05665244
Study type Observational
Source University of Texas Southwestern Medical Center
Contact Shumon Dhar, MD
Phone 214-645-7034
Email Shumon.Dhar@UTSouthwestern.edu
Status Recruiting
Phase
Start date December 26, 2022
Completion date December 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT03363698 - MCT and Capsaicin Provocation Challenge in Diagnosis of Chronic Cough